Clinical Trial Update: Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating abiraterone with different steroid regimens to prevent mineralocorticoid excess side effects in prostate cancer before chemotherapy; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-05-11